- Home
- CORT vs BEPC Comparison
CORT vs BEPC Comparison
Compare CORT & BEPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- BEPC
- Stock Information
- Founded
- CORT 1998
- BEPC 2019
- Country
- CORT United States
- BEPC United States
- Employees
- CORT N/A
- BEPC N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- BEPC Electric Utilities: Central
- Sector
- CORT Health Care
- BEPC Utilities
- Exchange
- CORT Nasdaq
- BEPC Nasdaq
- Market Cap
- CORT 7.5B
- BEPC 6.1B
- IPO Year
- CORT N/A
- BEPC N/A
- Fundamental
- Price
- CORT $69.15
- BEPC $36.80
- Analyst Decision
- CORT Strong Buy
- BEPC Buy
- Analyst Count
- CORT 4
- BEPC 3
- Target Price
- CORT $142.00
- BEPC $33.67
- AVG Volume (30 Days)
- CORT 856.9K
- BEPC 873.8K
- Earning Date
- CORT 08-05-2025
- BEPC 08-01-2025
- Dividend Yield
- CORT N/A
- BEPC 4.05%
- EPS Growth
- CORT 8.36
- BEPC N/A
- EPS
- CORT 1.14
- BEPC N/A
- Revenue
- CORT $685,446,000.00
- BEPC $3,923,000,000.00
- Revenue This Year
- CORT $35.85
- BEPC $44.37
- Revenue Next Year
- CORT $35.22
- BEPC $7.44
- P/E Ratio
- CORT $60.53
- BEPC N/A
- Revenue Growth
- CORT 30.93
- BEPC N/A
- 52 Week Low
- CORT $32.33
- BEPC $23.73
- 52 Week High
- CORT $117.33
- BEPC $36.96
- Technical
- Relative Strength Index (RSI)
- CORT 45.05
- BEPC 69.87
- Support Level
- CORT $67.44
- BEPC $35.86
- Resistance Level
- CORT $73.78
- BEPC $36.96
- Average True Range (ATR)
- CORT 2.08
- BEPC 0.78
- MACD
- CORT -0.31
- BEPC 0.11
- Stochastic Oscillator
- CORT 26.97
- BEPC 96.31
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About BEPC Brookfield Renewable Corporation
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia, and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners LP and Brookfield Renewable Corp.